CanSino Biologics Inc. (OTCMKTS:CASBF) Short Interest Update

CanSino Biologics Inc. (OTCMKTS:CASBFGet Free Report) was the recipient of a significant drop in short interest in December. As of December 31st, there was short interest totalling 10,800 shares, a drop of 46.0% from the December 15th total of 20,000 shares. Based on an average daily trading volume, of 400 shares, the short-interest ratio is currently 27.0 days.

CanSino Biologics Price Performance

CASBF remained flat at C$3.30 on Wednesday. The firm’s 50 day simple moving average is C$3.92 and its two-hundred day simple moving average is C$3.11. CanSino Biologics has a 52-week low of C$1.86 and a 52-week high of C$4.35.

About CanSino Biologics

(Get Free Report)

CanSino Biologics Inc develops, manufactures, and commercializes vaccines in the People's Republic of China. The company develops Convidecia and the Ad5-nCoV for Inhalation vaccines to recombinant novel coronavirus disease; Ad5-EBOV, an Ebola virus vaccine; and MCV2 and MCV4 vaccines for the prevention of N.

See Also

Receive News & Ratings for CanSino Biologics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CanSino Biologics and related companies with MarketBeat.com's FREE daily email newsletter.